Efficacy of Donepezil in the posterior variant of Alzheimers disease (Posterior Cortical Atrophy) Study.

Trial Profile

Efficacy of Donepezil in the posterior variant of Alzheimers disease (Posterior Cortical Atrophy) Study.

Completed
Phase of Trial: Phase II

Latest Information Update: 21 Apr 2017

At a glance

  • Drugs Donepezil (Primary)
  • Indications Alzheimer's disease
  • Focus Therapeutic Use
  • Acronyms DONIPAD
  • Most Recent Events

    • 05 Jan 2012 Actual end date 30 Jun 2011 added as reported by UKCRN.
    • 05 Jan 2012 Status changed from active, no longer recruiting to completed as reported by UKCRN.
    • 06 Jul 2011 United Kingdom Clinical Research Network reports accrual to date changed from 85% to 90%.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top